FIERRO, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 526
EU - Europa 303
AS - Asia 210
AF - Africa 1
Totale 1.040
Nazione #
US - Stati Uniti d'America 523
IE - Irlanda 96
SG - Singapore 61
IT - Italia 58
UA - Ucraina 55
VN - Vietnam 55
CN - Cina 34
HK - Hong Kong 34
RU - Federazione Russa 22
DE - Germania 20
FI - Finlandia 16
TR - Turchia 13
GB - Regno Unito 10
FR - Francia 6
AT - Austria 5
KR - Corea 4
SE - Svezia 4
BE - Belgio 3
CZ - Repubblica Ceca 3
CA - Canada 2
CH - Svizzera 2
LB - Libano 2
LK - Sri Lanka 2
NL - Olanda 2
UZ - Uzbekistan 2
IN - India 1
JP - Giappone 1
MX - Messico 1
PL - Polonia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 1.040
Città #
Chandler 143
Dublin 94
Dong Ket 55
Singapore 52
San Mateo 44
Hong Kong 34
Jacksonville 32
Ann Arbor 26
Boardman 25
Santa Clara 21
Medford 20
Princeton 20
Lawrence 19
Altamura 17
Beijing 14
Izmir 13
Wilmington 13
Rome 10
Saint Petersburg 10
Perugia 9
Munich 8
Andover 7
Des Moines 6
Redmond 6
San Diego 6
Amelia 4
Dearborn 4
Los Angeles 4
San Paolo di Civitate 4
Seoul 4
Vienna 4
Brussels 3
Ashburn 2
Colombo 2
Helsinki 2
Moscow 2
New York 2
Newton Stewart 2
Olomouc 2
Trento 2
Woodbridge 2
Amsterdam 1
Ancona 1
Atlanta 1
Blandford Forum 1
Calgary 1
Changsha 1
Den Haag 1
Fuzhou 1
Houston 1
Kiev 1
London 1
Norwalk 1
Orange 1
Riyadh 1
Shanghai 1
Tappahannock 1
Termoli 1
Tokyo 1
Warsaw 1
Windsor 1
Totale 769
Nome #
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 88
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 77
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 74
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 74
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 73
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 65
Critical limb ischemia. 57
Possible role of platelet activation in the cardiovascular complications associated with HIV infection: differential effects of abacavir (ABC) vs. tenofovir (TDF) 53
Coinheritance of three novel FV gene mutations in a patient with a severe FV deficiency. 51
Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia. 51
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 46
Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs 45
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. 43
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 43
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry 43
Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease 42
Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study. 41
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 39
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure 39
First Diagnosis of Hemophilia B in a Nonagenarian 38
Totale 1.082
Categoria #
all - tutte 4.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 0 0 0 0 0 4 9 2 16 5 10 2
2020/2021171 6 10 0 9 45 0 21 1 9 6 9 55
2021/2022134 1 33 1 1 6 1 0 45 2 0 22 22
2022/2023381 21 81 0 31 43 35 0 18 135 1 14 2
2023/2024133 10 10 7 8 4 0 26 1 11 3 27 26
2024/2025100 4 22 3 29 27 15 0 0 0 0 0 0
Totale 1.082